Patents by Inventor Kamlesh Kanzariya

Kamlesh Kanzariya has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • An Improved Process Of Preparation Of Ivosidenib
    Publication number: 20220324838
    Abstract: The present invention relates to an improved process of preparation of Ivosidenib a compound of Formula (I). More particularly, present invention provides process of preparation of intermediates. Also provide process of preparation of amorphous form of Ivosidenib. Further, present invention provides process of preparation of chirally pure Ivosidenib a compound of Formula (I).
    Type: Application
    Filed: August 6, 2020
    Publication date: October 13, 2022
    Applicant: Alembic Pharmaceuticals Limited
    Inventors: Vittal Tvsk, Sanjiv Tomer, Kamlesh Kanzariya, Harsh Patel
  • Polymorphic forms of vortioxetine and its pharmaceutically acceptable salts
    Patent number: 10071092
    Abstract: The present invention provides polymorphic forms of Vortioxetine of and its pharmaceutically acceptable salts. Specifically the present invention relates to the novel crystalline forms of Vortioxetine or its pharmaceutically acceptable salts. Moreover, the present invention also provides an amorphous form of Vortioxetine hydrobromide and a stable amorphous co-precipitate of Vortioxetine hydrobromide with pharmaceutically acceptable excipients.
    Type: Grant
    Filed: April 21, 2015
    Date of Patent: September 11, 2018
    Inventors: Venkat Raman Jayaraman, Sanjiv Tomer, Piyush Rana, Kamlesh Kanzariya, Sunit Kumar, Nilav Patel, Manoj Borsaniya, Sudhir Shah, Anand Thirunavakarasu
  • NOVEL POLYMORPHIC FORMS OF VORTIOXETINE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS
    Publication number: 20170189394
    Abstract: The present invention provides polymorphic forms of Vortioxetine of and its pharmaceutically acceptable salts. Specifically the present invention relates to the novel crystalline forms of Vortioxetine or its pharmaceutically acceptable salts. Moreover, the present invention also provides an amorphous form of Vortioxetine hydrobromide and a stable amorphous co-precipitate of Vortioxetine hydrobromide with pharmaceutically acceptable excipients.
    Type: Application
    Filed: April 21, 2015
    Publication date: July 6, 2017
    Applicant: ALEMBIC PHARMACEUTICALS LIMITED
    Inventors: Venkat Raman Jayaraman, Sanjiv Tomer, Piyush Rana, Kamlesh Kanzariya, Sunit Kumar, Nilav Patel, Manoj Borsaniya, Sudhir Shah, Anand Thirunavakarasu